RAS and BRAF mutational study in synchronous colorectal cancer

被引：0
|
作者：
Sepodes, B. [1 ]
Gama, J. [1 ]
Gomes, A. [1 ]
Teixeira, P. [1 ]
Jesus, A. [1 ]
Fontinha, G. [1 ]
Madeira, J. [1 ]
Ramalhosa, F. [1 ]
Faria, C. [1 ]
Pimentao, M. B. [1 ]
Almeida, V. [1 ]
Oliveira Caetano, R. [1 ]
Cipriano, M. A. [1 ]
机构：
[1] CHUC, Coimbra, Portugal
来源：
VIRCHOWS ARCHIV | 2021年 / 479卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-06-020
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [21] Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer
    Santos, Cristina
    Azuara, Daniel
    Garcia-Carbonero, Rocio
    Garcia Alfonso, Pilar
    Carrato, Alfredo
    Elena Elez, Ma
    Gomez, Auxiliadora
    Losa, Ferran
    Montagut, Clara
    Massuti, Bartomeu
    Navarro, Valenti
    Varela, Mar
    Lopez-Doriga, Adriana
    Moreno, Victor
    Valladares, Manuel
    Luis Manzano, Jose
    Maria Vieitez, Jose
    Aranda, Enrique
    Sanjuan, Xavier
    Tabernero, Josep
    Capella, Gabriel
    Salazar, Ramon
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (09) : 1999 - 2007
  • [22] Clinical features of Japanese patients with detailed RAS/BRAF mutant colorectal cancer
    Satake, H.
    Kotaka, M.
    Ogata, M.
    Yasui, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S116 - S116
  • [23] RAS and BRAF genes as biomarkers and target for personalised colorectal cancer therapy: An update
    Ooi, Zhuan-Shern
    Pang, Siew-Wai
    Teow, Sin-Yeang
    MALAYSIAN JOURNAL OF PATHOLOGY, 2022, 44 (03) : 415 - 428
  • [24] Colorectal Cancer Modeling with Organoids: Discriminating between Oncogenic RAS and BRAF Variants
    Post, Jasmin B.
    Roodhart, Jeanine M. L.
    Snippert, Hugo J. G.
    TRENDS IN CANCER, 2020, 6 (02): : 111 - 129
  • [25] New advances in the clinical management of RAS and BRAF mutant colorectal cancer patients
    Carlos Ruffinelli, Jose
    Santos Vivas, Cristina
    Sanz-Pamplona, Rebeca
    Moreno, Victor
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (01) : 65 - 79
  • [26] Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
    Ottaiano, Alessandro
    Berretta, Massimiliano
    Von Arx, Claudia
    Capozzi, Monica
    Caraglia, Michele
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Current therapy of advanced colorectal cancer according to RAS/RAF mutational status
    Gábor Lakatos
    Claus-Henning Köhne
    György Bodoky
    Cancer and Metastasis Reviews, 2020, 39 : 1143 - 1157
  • [28] A study of advanced colorectal cancer with BRAF mutation
    Ryogo, Himori
    Hiro-O, Yamano
    Hiro-O, Matsushita
    Kenjiro, Yoshikawa
    Eiji, Harada
    Ryo, Takagi
    Yoshihito, Tanaka
    Michiko, Nakaoka
    Yuko, Katano
    Kentaro, Sato
    Makoto, Eizuka
    Tamotsu, Sugai
    Hironori, Aoki
    Eiichiro, Yamamoto
    Hiromu, Suzuki
    Yasushi, Imai
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 61 - 61
  • [29] RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer
    Zhu, Liuying
    Wang, Yuanhe
    Zhou, Yang
    Dong, Qian
    Liu, Yunpeng
    Zhang, Jingdong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [30] Current therapy of advanced colorectal cancer according to RAS/RAF mutational status
    Lakatos, Gabor
    Koehne, Claus-Henning
    Bodoky, Gyorgy
    CANCER AND METASTASIS REVIEWS, 2020, 39 (04) : 1143 - 1157
12345